openPR Logo
Press release

Pneumonia Vaccines Market Qualitative Insights On Application 2028

09-24-2019 01:26 PM CET | Health & Medicine

Press release from: TMR Research

TMR Research

TMR Research

Global Pneumonia Market: Overview

Pneumonia vaccines are recommended for adults and children for a wide range of clinical conditions. The bacteria Streptococcus pneumoniae is responsible for pneumococcal infections causing otitis media, bacteremia, pneumonia, and meningitis. Unconjugated as well as conjugated pneumococcal polysaccharide vaccines have been used with success for reducing the rate of pneumococcal infections, especially in adults and children.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6050

Considerable research has been made in expanding understanding of pneumococcal immunobiology. In the light of rapidly aging populations in low and middle-income countries, vaccine manufacturers have focused on vaccine efficacy, apart from cost effectiveness. Demand for prevention of invasive pneumococcal disease has helped shape the approaches for manufacturers. At-risk populations include individuals with diabetes, asthma, chronic obstructive pulmonary disease, human immunodeficiency virus (HIV), sickle cell disease, and cardiovascular diseases.

Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6050

The report on the global pneumonia vaccines market takes a closer look at winning imperatives by top players, technological advances, and the risk factors related to specific factors.

Global Pneumonia Vaccines Market: Key Developments

In recent years, vaccine manufacturers in the pneumonia vaccines market have started focusing on immunocompromised populations and children. Particularly, their initiatives have facilitated the development of potential vaccine antigens. To this end, they are including most common serotypes for preventing invasive pneumococcal diseases in paediatrics.

Get Discount on Latest Report @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=6050

Pfizer Inc., a U.S.-based multinational pharmaceutical corporation, recently revealed (September 2019) that it has made headways in phase II study on its 20-valent pneumococcal conjugate vaccine. The proof-of-concept study is aimed at evaluating its candidate, PF-06482077 and the data recently threw open encouraging results. The company is developing its pneumococcal vaccine for treating invasive diseases and otitis media in healthy infant populations. The candidate, the company found similar safety profile, as its Prevnar 13, a 13-valent pneumococcal conjugate vaccine. Of note, it contains 20 serotypes and the data showed a positive immune response.

The pharmaceutical company hopes to test the efficacy of the candidate for adult populations. To this end, it announced that it enrolled three phase III clinical trials. This is a lucrative business for numerous other top pharmaceutical companies. A case in point is Merck developing 15-valent pneumococcal conjugate vaccine candidate, V114.

Global Pneumonia Vaccines Market: Growth Dynamics

Over the past few years, several pharmaceutical and biopharmaceuticals have enrolled themselves in evaluating candidates of developing pneumococcal conjugate vaccines. This type of vaccine has been occupying sizable shares in the market. Their efforts are invigorating the drug pipeline in the pneumonia vaccines market. Mounting concern of the risk of community-acquired pneumonia is also boosting new developments in various developing and developed countries. The awareness about preventive care in community-acquired pneumonia has reinforced the need for timely vaccination against pneumococcus.

Patients with chronic pulmonary conditions show considerable risk factor. The high risk of mortality of invasive pneumococcal diseases has spurred research pertaining to this patient cohort, thereby unlocking new prospects in the pneumonia vaccines market. In recent decades, shifting serotype dominance has led pharmaceuticals to doubt the efficacy of polysaccharide vaccine. This aside, increasing trend of antibiotic resistance has spurred research in pneumococcal vaccines that can cover against wide range of pneumococci antigens. This has opened new avenues in the pneumonia vaccines market.

Growing focus of NGOs and global agencies on pneumonia prevention strategies has augmented the role of vaccines. These organizations have been relentlessly working on the affordability of pneumococci vaccines in low- and middle-income countries.

Global Pneumonia Vaccines Market: Regional Analysis

Some of the key regional markets for pneumonia vaccines are North America, Europe, Asia Pacific, and LAMEA. Of these, North America has made considerable progress in vaccine developments. Particularly, progress made in development of vaccines for the development of invasive pneumococcal diseases has also reinforced lucrative avenues to vaccine manufacturers. Meanwhile, Asia Pacific is witnessing new advances in vaccine strategy. This has opened new revenue streams in the global pneumonia vaccines market.

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pneumonia Vaccines Market Qualitative Insights On Application 2028 here

News-ID: 1836827 • Views: …

More Releases from TMR Research

Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - 2031
Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - …
Automotive Vision System Market: Introduction A system that increases the vehicle driver's perception during night or bad weather conditions is termed as Automotive night vision system (ANVS). The system is otherwise beyond the reach of the vehicle's headlights, thereby prevents accidents at night. It can also be defined as a system which assists the driver by increasing visibility during bad whether while providing safety. Vehicle which have automotive vision system integrated are…
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market: Snapshot The waste heat recovery market has been expected to reach a valuation of US$ 65.87 Bn and expand at a CAGR of 6.90% in the foreseeable years from 2020 to 2030. The growth opportunities in the waste heat recovery market are attributed to the increasing prices of electricity and energy in the emerging economies. In addition to this, government regulations and incentives are also estimated to contribute…
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2021 to 2031.
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Ma …
Global Physical Fitness Equipment Market: Snapshot The physical fitness equipment market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2020 to 2030. The revenue generation opportunities in the physical fitness equipment market are attributed to the increasing enthusiasm among people toward fitness. In recent years, the fitness industry has been growing at a noticeable speed owing to…
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Growing Regions like North America, Europe and Asia Pacific.
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Grow …
Global Molecular Spectrometry Market: Snapshot  Molecular spectrometry examines and quantifies the response of molecules on interaction with known amounts of energy. Molecules have some energy levels that can be studied by determining the molecule's energy exchange through emission or absorbance. Molecular spectrometry involves studying emission, absorption, or scattering of electromagnetic waves by atoms or molecules to quantitatively and qualitatively study atoms, molecules or physical processes. The interaction of matter with radiation…

All 5 Releases


More Releases for Pneumonia

Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills. Read Report Overview -…
Industry Dynamics of Ventilator-associated Pneumonia
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview: The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH.  Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market.  Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
Global Pneumonia Therapeutics Market 2018 – 2023
Global Pneumonia Therapeutics Market 2018–2023 Poised for xx% Growth Planet Market Research has recently added a market study named Global Pneumonia Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 with prime importance on the forecast period from 2018 to 2023. The report is an in-depth analysis of the market for pneumonia therapeutics and covers various driving factors, restraints, opportunities and challenges affecting the market’s growth. Pneumonia is an…
Pneumonia Drug Development Market Focuses on Top Players (Hospital Acquired Pneu …
Pneumonia Drug Development Market study provides comprehensive data which enhances the understanding, scope and application of this report. Polyamides, polyethylene, nylons, epoxy resins, polysulfones, polyphthalamides, polyesters, and polycarbonates are some key forms of plastics that are employed in electronic components. The insulation properties of plastic account for its in depth use in electrical and electronic components of machines and gadgets. Report Consultant has introduced a new report titled as Global Pneumonia…
Pneumonia Testing Market Opportunity Analysis, 2018-2026
Pneumonia is a lung infection caused by bacteria, viruses or fungi, primarily affecting the small sir sacs known as alveoli. The most common bacterial type that causes pneumonia is Streptococcus pneumoniae. The symptoms for pneumonia include, fever, chills, cough, shortness of breath and fatigue. To detect whether, a person has pneumonia are blood tests, chest X-ray, pulse oximetry, and Sputum test. Further, if the patients is older than age 65,…